CORD-19:48b81081bbcbdbea648394d8bf2adf370b36e44c / 176014-176242 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T88783","span":{"begin":0,"end":11},"obj":"Sentence"},{"id":"T42153","span":{"begin":12,"end":228},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Conclusion: The higher the likelihood of receiving active treatment (a drug as compared to a placebo), the lower the response rate to both placebo and the drug in IBS, at the expense of a poorer discrimination between DR and PR."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T400","span":{"begin":0,"end":228},"obj":"Epistemic_statement"}],"text":"Conclusion: The higher the likelihood of receiving active treatment (a drug as compared to a placebo), the lower the response rate to both placebo and the drug in IBS, at the expense of a poorer discrimination between DR and PR."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T228","span":{"begin":0,"end":11},"obj":"Sentence"},{"id":"T229","span":{"begin":12,"end":228},"obj":"Sentence"}],"text":"Conclusion: The higher the likelihood of receiving active treatment (a drug as compared to a placebo), the lower the response rate to both placebo and the drug in IBS, at the expense of a poorer discrimination between DR and PR."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T659","span":{"begin":163,"end":166},"obj":"Disease"},{"id":"T651","span":{"begin":163,"end":166},"obj":"Disease"}],"attributes":[{"id":"A659","pred":"mondo_id","subj":"T659","obj":"http://purl.obolibrary.org/obo/MONDO_0005052"},{"id":"A660","pred":"mondo_id","subj":"T659","obj":"http://purl.obolibrary.org/obo/MONDO_0007813"},{"id":"A14960","pred":"mondo_id","subj":"T651","obj":"http://purl.obolibrary.org/obo/MONDO_0005052"},{"id":"A40508","pred":"mondo_id","subj":"T651","obj":"http://purl.obolibrary.org/obo/MONDO_0007813"}],"text":"Conclusion: The higher the likelihood of receiving active treatment (a drug as compared to a placebo), the lower the response rate to both placebo and the drug in IBS, at the expense of a poorer discrimination between DR and PR."}